Drug Shortage Report for TOBREX

Last updated on 2019-02-05 History
Report ID 69257
Drug Identification Number 00513962
Brand name TOBREX
Common or Proper name TOBREX 0.3% SOLN 5 ML
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) TOBRAMYCIN
Strength(s) .3%
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC
Packaging size 5ML
ATC code S01AA
ATC description ANTIINFECTIVES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-12-11
Estimated end date 2019-02-04
Actual end date 2019-02-04
Shortage status Resolved
Updated date 2019-02-05
Company comments
Health Canada comments
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2019-02-05 English Compare
v13 2019-02-04 French Compare
v12 2019-02-04 English Compare
v11 2019-02-01 French Compare
v10 2019-02-01 English Compare
v9 2019-01-30 French Compare
v8 2019-01-30 English Compare
v7 2019-01-25 French Compare
v6 2019-01-25 English Compare
v5 2018-12-18 French Compare
v4 2018-12-18 English Compare
v3 2018-12-12 English Compare
v2 2018-12-11 French Compare
v1 2018-12-11 English Compare